This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to The Administrators of Tulane Educational Fund, doing business as Tulane University. The contract is a delivery order under the "Simian Vaccine Evaluation Units 2013-2020" indefinite delivery contract, with a ceiling value of $9,035,728.24 and a completion date of April 30, 2022. The contract is for "Simian...
This $1,422,288.62 federal delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the Administrators of Tulane Educational Fund, doing business as Tulane University, a private university in New Orleans, Louisiana. The contract is for "Simian Vaccine Evaluation Units" and has an ultimate completion date of June 30, 2020. It is a cost-no-fee contract issued under a...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to The Administrators of Tulane Educational Fund, doing business as Tulane University. The $150,969.93 award provides administrative and technical support for ongoing studies and the final transition under the Simian Vaccine Evaluation Units program, which is a major program code associated with this contract. The...
This federal contract award, valued at $1,539,882.20, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to The Administrators of Tulane Educational Fund, doing business as Tulane University. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) vehicle called the Simian Vaccine Evaluation Units (SVEUS), which supports NIAID's mission of advancing research to understand, prevent, and treat infectious diseases. Under this task order,...
This is a $3,690,803.53 Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to The Administrators of Tulane Educational Fund, doing business as Tulane University. The contract supports the Simian Vaccine Evaluation Units (SVEUS) major program and is for preclinical research services, including small animal models, non-human primate models, animal replacement and non-traditional animal models, and specialized reagent generation and distribution. The...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $645,369.00 delivery order to The Administrators of the Tulane Educational Fund, doing business as Tulane University, on August 5, 2019. The award, which is not set aside, is for the Conduct Study P209 under the Simian Vaccine Evaluation Units 2013-2020 master contract vehicle. Tulane University, a private non-profit university located in New...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,041,214 delivery order contract to Tulane University to conduct a study titled "CONDUCT STUDY P214". This contract is under NIAID's Simian Vaccine Evaluation Units (SVEUS) Indefinite Delivery Contract (IDC), a $146,300,000 multiple-award vehicle for preclinical research support services. The contract has a period of performance through July 23, 2026 and does not contain a set-aside designation. Tulane...
This federal contract award, valued at $1,722,748.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID) to The Administrators of Tulane Educational Fund, doing business as Tulane University. The contract is for a study described as "CONDUCT STUDY 222" and has an ultimate completion date of April 11, 2027. The contract is a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) vehicle called the "Simian Vaccine Evaluation Units"...
This is a delivery order award to The Administrators Of Tulane Educational Fund, doing business as Tulane University, under the National Institute of Allergy and Infectious Diseases' (NIAID) Simian Vaccine Evaluation Units master contract. The $1,796,343 award is for a study titled "CONDUCT STUDY P217" with a period of performance through October 30, 2026. The contract does not have a set-aside designation. As a comprehensive research university, Tulane University has extensive...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Administrators Of The Tulane Educational Fund, doing business as Tulane University. The contract is for a study with the ID "CONDUCT STUDY P223" and has a ceiling value of $2,180,168.00. It is a delivery order under the Simian Vaccine Evaluation Units master IDIQ contract. The contract does not have a set-aside designation and has an ultimate completion...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to The Administrators of Tulane Educational Fund, doing business as Tulane University, a private university in New Orleans, Louisiana. The contract is for Simian Vaccine Evaluation Units, with a ceiling value of $1,833,205.37 and a performance period through April 30, 2022. The contract is a delivery order issued under the Simian Vaccine Evaluation Units 2013-2020 Indefinite Delivery Contract, a multiple-award contract vehicle that provides preclinical development support services, including animal model studies, product manufacturing, and scientific and quality services, to facilitate future procurements around pediatric and HIV prevention science research priorities. This contract award does not have a set-aside designation.